Effect of Photodynamic Therapy on Skin Microbiome. Single Center Study (PHOMIC-III) (NCT05676801) | Clinical Trial Compass
UnknownEarly Phase 1
Effect of Photodynamic Therapy on Skin Microbiome. Single Center Study (PHOMIC-III)
Switzerland20 participantsStarted 2023-02-04
Plain-language summary
The overarching aim of this research project is to prevent orthopedic implant-associated infections. This study aims to investigate if PDT has an effect on bacterial skin colonization in order to improve skin antisepsis strategies for the prevention of surgical site infections.
Who can participate
Age range18 Years – 100 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Healthy male and female participants ≥ 18 years who volunteer for the pilot study, in which a routine photodynamic treatment at the Department of Dermatology will be performed and effect of skin colonization will be analyzed, and who signed an informed consent (after information about the project)
Exclusion Criteria:
* Pregnant and breastfeeding women
* Participants with inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.,
* Participants taking antibiotics in the 14 days prior to PDT or until follow-up at 21 days
* Participants who received oral retinoid therapy within the last 6 months
* Participants who received anti-inflammatory agents as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) within the 14 days prior and after the PDT
* Participants taking any photosensitizing drugs within 4 weeks prior to PDT
* Participants who had a history of photosensitivity disorder
* Fitzpatrick's skin phototype V-VI